In addition to histological studies, our current study included analyses of TEAD1 mRNA levels and genomic deletion or loss of TEAD1 with all the data supporting a tumor suppressive function for TEAD1 in PCa. The gene discussed is TEAD1; the disease is posterior cortical atrophy.